PSNYW
Polestar C-1·NASDAQ
--
--(--)
--
--(--)
1.16 / 10
Underperform
The company's fundamental health is concerning, scoring only 1.2 out of 10. Key red flags include a net cash-flow from operations that fell 85.9% YoY and an accounts-receivable turnover ratio in the second quartile, both historically linked to negative monthly returns. Although total-assets growth is slightly positive, the overall operating cycle of 113 days remains in a high-risk group, reinforcing a guarded investment stance.
Analysis Checks(2/4)
Total assets (growth rate compared to beginning of year %)
Value-10.15
Score2/3
Weight22.95%
1M Return-3.87%
Value-10.15
Score2/3
Weight22.95%
1M Return-3.87%
Accounts receivable turnover ratio
Value5.40
Score0/3
Weight32.88%
1M Return-6.66%
Value5.40
Score0/3
Weight32.88%
1M Return-6.66%
Operating cycle
Value113.12
Score2/3
Weight13.48%
1M Return-2.14%
Value113.12
Score2/3
Weight13.48%
1M Return-2.14%
Net cash flow from operating activities (YoY growth rate %)
Value-85.92
Score0/3
Weight30.70%
1M Return-6.00%
Value-85.92
Score0/3
Weight30.70%
1M Return-6.00%
Total assets (growth rate compared to beginning of year %)
Value-10.15
Score2/3
Weight22.95%
1M Return-3.87%
Value-10.15
Score2/3
Weight22.95%
1M Return-3.87%
Operating cycle
Value113.12
Score2/3
Weight13.48%
1M Return-2.14%
Value113.12
Score2/3
Weight13.48%
1M Return-2.14%
Accounts receivable turnover ratio
Value5.40
Score0/3
Weight32.88%
1M Return-6.66%
Value5.40
Score0/3
Weight32.88%
1M Return-6.66%
Net cash flow from operating activities (YoY growth rate %)
Value-85.92
Score0/3
Weight30.70%
1M Return-6.00%
Value-85.92
Score0/3
Weight30.70%
1M Return-6.00%
Is PSNYW undervalued or overvalued?
- PSNYW scores 1.16/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -105.95% net margin, -0.08 P/E ratio, -0.05 P/B ratio, and -76371.22% earnings growth, these metrics solidify its Underperform investment rating.
